No one is going to come after you for de-prescribing.
We've identified 240 MED and prescribing to patients who have 4 or more prescribers as major factors in inviting scrutiny.
However, other metrics being looked at include
% of beneficiaries on greater than 90 MED for 3 months, and
avg. number of days prescribed for each beneficiary.
-Both factors likely to be elevated in de-prescribing clinics.
It's becoming my gut sense that running de-prescribing clinics may well be too risky for solo and small group practices, who are essentially naked.
Hospital employed and academic physicians at least have some layer of protection.
A couple of anecdotes:
-I have a local colleague, who I've always thought had a deprescribing practice style and who reviews opioid cases for the medical board, and who has now been cited by the medical board. I reviewed the online public accusation and there was no mention of any patient deaths having occurred.
-I received a recent e-blast from my county medical society that the state's medical board, in coordination with the state department of health, has been reviewing cases of patient death, retroactive to 2012, where the patient was on at least 80 MED.
I recall Algos being chided as being alarmist in a previous thread describing local litigation in FL.
This s**t is closing in from all sides (local, state, federal).
Our professional societies have no great advice on these issues.
Maybe we can come up with consensus SDN Pain Forum Guidelines, designed to mitigate patient and med-legal risk, across all practice settings.